These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 2888712

  • 1. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis.
    Wolf ME, DeWolfe AS, Mosnaim AD.
    Hillside J Clin Psychiatry; 1987; 9(1):3-11. PubMed ID: 2888712
    [Abstract] [Full Text] [Related]

  • 2. Vulnerability to tardive dyskinesia.
    Wolf ME, DeWolfe AS, Ryan JJ, Lips O, Mosnaim AD.
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [Abstract] [Full Text] [Related]

  • 3. The clinical association of tardive dyskinesia and drug-induced parkinsonism.
    Wolf ME, Chevesich J, Lehrer E, Mosnaim AD.
    Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032
    [No Abstract] [Full Text] [Related]

  • 4. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC, Atbaşoğlu EC, Balaban H.
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [Abstract] [Full Text] [Related]

  • 5. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G, Cole JO, Schniebolk S, Salomon M.
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [Abstract] [Full Text] [Related]

  • 6. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM.
    J Clin Psychiatry; 2004 Sep; 65 Suppl 9():16-20. PubMed ID: 15189107
    [Abstract] [Full Text] [Related]

  • 7. Tardive dyskinesia and the primary psychiatric diagnosis.
    Yassa R, Nair V, Schwartz G.
    Psychosomatics; 1984 Feb; 25(2):135-8. PubMed ID: 6142494
    [No Abstract] [Full Text] [Related]

  • 8. Prevention and management of tardive dyskinesia.
    Jeste DV, Wyatt RJ.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [Abstract] [Full Text] [Related]

  • 9. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA, Mythily, Lum A, Huak CY, Kane J.
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [Abstract] [Full Text] [Related]

  • 10. [Psychopathology and cognitive disorders in chronic schizophrenic patients with tardive dyskinesia].
    Kaiser W.
    Nervenarzt; 1989 Apr; 60(4):206-12. PubMed ID: 2566936
    [No Abstract] [Full Text] [Related]

  • 11. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR.
    Psychiatr Dev; 1987 Apr; 5(4):301-19. PubMed ID: 2895467
    [Abstract] [Full Text] [Related]

  • 12. Tardive dyskinesia and glucid metabolism.
    Brousse G, Meary A, Mouret J, Blanc O, Hueber T, Lemoine P, Llorca PM, Lachaux B.
    Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
    [Abstract] [Full Text] [Related]

  • 13. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [Abstract] [Full Text] [Related]

  • 14. The prevalence of tardive dyskinesia in geropsychiatric outpatients.
    Chacko RC, Root L, Marmion J, Molinari V, Adams GL.
    J Clin Psychiatry; 1985 Feb; 46(2):55-7. PubMed ID: 2857168
    [Abstract] [Full Text] [Related]

  • 15. [Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital].
    Bourgeois M.
    Encephale; 1977 Feb; 3(4):299-320. PubMed ID: 611013
    [Abstract] [Full Text] [Related]

  • 16. Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesia.
    Jeste DV, Neckers LM, Wagner RL, Wise CD, Staub RA, Rogol A, Potkin SG, Bridge TP, Wyatt RJ.
    J Clin Psychiatry; 1981 Feb; 42(2):75-7. PubMed ID: 6109719
    [Abstract] [Full Text] [Related]

  • 17. Factors related to the severity of tardive dyskinesia.
    Wade JB, Hart RP, Dougherty LM.
    Brain Cogn; 1993 Sep; 23(1):71-80. PubMed ID: 8105823
    [Abstract] [Full Text] [Related]

  • 18. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
    Richardson MA, Haugland G, Craig TJ.
    Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
    [Abstract] [Full Text] [Related]

  • 19. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM.
    J Clin Psychiatry; 2000 Oct; 61 Suppl 4():15-20. PubMed ID: 10739326
    [Abstract] [Full Text] [Related]

  • 20. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE, Kuskowski MA, Caligiuri MP.
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.